‹ All Posts
Shree Dhanraksha Securities

17th Mar 2025 · SEBI-Registered Analyst

Mankind Pharma

MANKIND
strong brand presence and continuous investment in research and development have solidified its position in both domestic and international markets. With consistent financial performance and high-profit margins, the company is expected to see a 32% upside, benefiting from the expanding pharmaceutical industry.

#WatchOutFor#TrendingSectors#MacroViews#Miscellaneous#PsychologyofMoney
234 likes·83 comments